Showcasing major breakthroughs in cancer care from worldwide clinical trials, Project Oncology® educ
Host: Jacob Sands, MD Guest: Shirish Gadgeel, MD Immunotherapy using checkpoint in
Host: Jacob Sands, MD Guest: Benjamin Kann, MD Artificial intelligence-based model
Host: Jacob Sands, MD Guest: Brad McGregor, MD Non-clear cell renal cell carcinoma
Host: Jacob Sands, MD Guest: Derek Raghavan, MD, PhD, FACP, FRACP CT scans have th
Host: Jacob Sands, MD Guest: Millie Das, MD What are some of the latest advancemen
Host: Jacob Sands, MD Guest: Mark Awad, MD, PhD Immunotherapy has led to impressiv
Host: Jacob Sands, MD Guest: Mark Awad, MD, PhD What do we need to know about the
Guest: D. Ross Camidge, MD, PhD With only two targeted therapy options available for R
Guest: D. Ross Camidge, MD, PhD After starting on a RET inhibitor, what do you do? Dr.
Host: Jacob Sands, MD Guest: Lori Pierce, MD, FASTRO, FASCO With only 3% of practi
Host: Jacob Sands, MD Guest: Andrea B. McKee, MD Lung cancer screening is one of t
Host: Jacob Sands, MD Guest: Andrea B. McKee, MD How can a lung screening program
Host: Jacob Sands, MD Guest: Aaron S. Mansfield, MD There are different treatment
Host: Jacob Sands, MD Guest: Aaron S. Mansfield, MD Mesothelioma is a cancer with
Host: Jacob Sands, MD Guest: Pasi Antero Jänne, MD, PhD Once we’ve confirmed a pat
Host: Jacob Sands, MD Guest: Benjamin Levy, MD What is genomic testing, and how ha
Host: Jacob Sands, MD Guest: Lawrence Nathan Shulman, MD Oncology is a rapidly evo
Host: Jacob Sands, MD Guest: Lawrence Nathan Shulman, MD How do challenges in our
Host: Jacob Sands, MD How has cancer care changed from the initial outbreak of the COV
Host: Jacob Sands, MD Cancer care has evolved since the initial outbreak of the COVID-
